Clinical Research Management Briefing – January 8, 2018
The American Society of Clinical Oncology will partner with two private organizations to analyze data secured from more than 100 U.S. oncology practices, in hopes of uncovering effective treatments and accelerating clinical trials.
STAT, December 21
A new book reflects on the growing pressures and challenges regulatory bodies face and the three factors that, in combination, can be used to measure “regulatory excellence.”
The Regulatory Review, January 2
As the future of clinical trials moves toward real-time decision making and resource allocation, biotech companies must do more to evolve their internal structure and processes accordingly.
MedCity News, January 2
Two new artificial intelligence (AI) systems to diagnose heart scans and detect lung cancer could dramatically reduce costs for England’s National Health Service (NHS) and improve accuracy.
BBC, January 2
The year ahead is poised to bring new investments in digital health to support clinical research, a continued evolution of patient engagement, and more sophisticated applications of risk and quality analytics.
Applied Clinical Trials, December 28
Recent efforts from the Chinese government to prioritize pharmaceutical innovation are paying off, with multiple companies pursuing Phase 3 trials for new cancer treatments.
The New York Times, January 3
An international group of researchers released new guidelines around how to include and protect cancer patients whose disease has spread to the central nervous system in clinical trials.
ScienceDaily, December 30Contact Us